Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Rothman

Showing results (921-930 of 952) with videos related to

Pageof 96
Sort By:
American Heart Journal|May 25, 2024
Framework of the strengths and challenges of clinically integrated trials: An expert panel reportAnthony E Peters, W Schuyler Jones, Brian Anderson, et al.
JAMA Psychiatry|November 24, 2017
Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical TrialDaniel C Javitt, Cameron S Carter, John H Krystal, et al.
Learning Health Systems|October 20, 2022
Training the next generation of learning health system scientistsPaula M Lozano, Meghan Lane-Fall, Patricia D Franklin, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 22, 2023
Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ)Susanna Naggie, Aaron Milstone, Mario Castro, et al.
Plos Neglected Tropical Diseases|July 19, 2021
The impact of dengue illness on social distancing and caregiving behaviorKathryn L Schaber, Amy C Morrison, William H Elson, et al.
Diabetes Care|September 15, 2023
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE TrialDennis I Narcisse, Hwasoon Kim, Lisa M Wruck, et al.
JAMA Cardiology|October 4, 2023
Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical TrialAmber Sleem, Mark B Effron, Amanda Stebbins, et al.
Ebiomedicine|April 22, 2020
Transcriptional and clonal characterization of B cell plasmablast diversity following primary and secondary natural DENV infectionAdam T Waickman, Gregory D Gromowski, Wiriya Rutvisuttinunt, et al.
Circulation. Heart Failure|February 12, 2017
Design and Rationale of a Randomized Trial of a Care Transition Strategy in Patients With Acute Heart Failure Discharged From the Emergency Department: GUIDED-HF (Get With the Guidelines in Emergency Department Patients With Heart Failure)Gregory J Fermann, Phillip D Levy, Peter Pang, et al.
American Heart Journal|June 8, 2023
Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLEKamal Gupta, Harsh Mehta, Hwasoon Kim, et al.
Pageof 96

Showing results (921-930 of 952) with videos related to

Sort By:
Pageof 96
American Heart Journal|May 25, 2024
Framework of the strengths and challenges of clinically integrated trials: An expert panel reportAnthony E Peters, W Schuyler Jones, Brian Anderson, et al.
JAMA Psychiatry|November 24, 2017
Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical TrialDaniel C Javitt, Cameron S Carter, John H Krystal, et al.
Learning Health Systems|October 20, 2022
Training the next generation of learning health system scientistsPaula M Lozano, Meghan Lane-Fall, Patricia D Franklin, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|January 22, 2023
Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ)Susanna Naggie, Aaron Milstone, Mario Castro, et al.
Plos Neglected Tropical Diseases|July 19, 2021
The impact of dengue illness on social distancing and caregiving behaviorKathryn L Schaber, Amy C Morrison, William H Elson, et al.
Diabetes Care|September 15, 2023
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease and Diabetes Mellitus: A Subgroup Analysis of the ADAPTABLE TrialDennis I Narcisse, Hwasoon Kim, Lisa M Wruck, et al.
JAMA Cardiology|October 4, 2023
Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical TrialAmber Sleem, Mark B Effron, Amanda Stebbins, et al.
Ebiomedicine|April 22, 2020
Transcriptional and clonal characterization of B cell plasmablast diversity following primary and secondary natural DENV infectionAdam T Waickman, Gregory D Gromowski, Wiriya Rutvisuttinunt, et al.
Circulation. Heart Failure|February 12, 2017
Design and Rationale of a Randomized Trial of a Care Transition Strategy in Patients With Acute Heart Failure Discharged From the Emergency Department: GUIDED-HF (Get With the Guidelines in Emergency Department Patients With Heart Failure)Gregory J Fermann, Phillip D Levy, Peter Pang, et al.
American Heart Journal|June 8, 2023
Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLEKamal Gupta, Harsh Mehta, Hwasoon Kim, et al.
Pageof 96